Natural hormone therapy for menopause

Gynecological Endocrinology

Volumn 26, Issue 2, 2010, Pages 81-85

  Mahmud, Khalid ^a  

^a Innovative Directions in Health   (United States)

Author keywords

Bio identical; Hormonal therapy; HRT; Menopause; Womens health

Indexed keywords

BIEST; ESTROGEN; PRASTERONE; PROGESTERONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMENTIA; FEMALE; HEART INFARCTION; HORMONAL THERAPY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; MENTAL DISEASE; NATURAL HORMONE THERAPY; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME; UNITED STATES; VAGINAL DRYNESS; WEIGHT REDUCTION;

ADULT; AGED; COGNITION; DEHYDROEPIANDROSTERONE; ESTRADIOL; ESTRIOL; FEMALE; HORMONE REPLACEMENT THERAPY; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PROGESTERONE; TESTOSTERONE;

EID: 75449088614     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590903184134     Document Type: Article

References (27)

1. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, et al. Estogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349: 523-534.
2. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the women's Health Initiative: a randomized trial. JAMA 2003;289:2673-2684.
3. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cry MG, Thomson CA, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy women: women's health initiative randomized trial. JAMA 2003;289:3243-3253. (Pubitemid 37430077)
4. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662.
5. Lemon HM. Oestriol and prevention of breast cancer. Lancer 1973;10:546-547.
6. Lemon HM. Pathophysiological considerations in the treatment of menopausal patients with oestrogens; the role of oestriol in the prevention of mammary carcinoma. Acta Endocrinol Suppl (copenh) 1980;233:17-27.
7. Siiteri PK. Pregnancy hormone estriol may reduce risk for breast cancer. Doctor's Guide 2002, www.pslgroup.com.
8. Vehkavaara S, Silveria A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost 2001;85:619-625.
9. Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: effects of continuouis combination, unopposed transdermal and low-potency estrogen regimens. Climacteric 2001;4:42-48.
10. Thijssen JH. Oestrogens, progestins and breast proliferation. Zentralbl Gynakol 1997;119(Suppl 2):43-47.
11. Petrakis NL, Wrensch MR, Ernster VL, Miike R, Murai J, Simberg N, Siiteri PK. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer 1987;40:587-591.
12. Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, Santner SJ, Tekmal R, Demers L, Pauley R, et al. Tissuespecific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 2000;95-112.
13. Formby B, Wiley TS. Progesterone inhibits growth and induces apoptosis in breast cancer cells: inverse effect on Bcl-2 and p53. Ann Clin Lab Sci 1998;28:360-369.
14. Formby B, Wiley TS. Bcl-2, surviving and variant CD44v7- v10 are down regulated and p53 upregulated in breast cancer cells by progesterone: inhibition of cell growth and apoptosis. Mol Cell Biochem 1999;202:53-61.
15. Zheng ZY, Zheng SM, Bay BH, Aw SE, Lin V C-L. Antiestrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells. Breast Cancer Res Treat 2008;110:111-125 Epub 2007 Aug 9.
16. Mohr PE, Wang DY, Gregory WM, Richards MA, Fentiman IS. Serum progesterone and prognosis in operable breast cancer. Br J Cancer 1996;7312:1552-1555.
17. Morales AJ,Nolan JJ,Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone inmen andwomen of advancing age. J Clin EndocrinolMetab 1994;78:1360-1367.
18. Maki PM, Gast MJ, Vieweg AJ, Burriss SW, Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 2007;69: 1322-1330.
19. Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 2004;292:2243-2248.
20. Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002;89(Supp l):12E-18E.
21. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA. 17-beta-Estradiol attenuates the acetycholine-induced coronary arterial constriction in women. Circulation 1995;92:5-8.
22. Lokkegaard E, Andreasen AH, Jacobsen RK, Nielsen LH, Agger C, Lidegaard O. Hormone therapy and risk of myocardial infarction: a national register study. Eur Heart J 2008; 29:2031-2041.
23. Hermsmeyer RK, Mishra RG, Pavcnik M, Uchida B, Axthelm MK, Stanczyk FZ, Burry KA, Illingworth DR, Kaski JC, Nordt FJ. Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone. Arterioscler Thromb Vasc Biol 2004;24:955-961.
24. Rosano GM, Webb CM, Chierchia S, Morgani GL, Gabraele M, Sarrel PM, de Ziegler D, Collins P. Natural progesterone, but not Medroxyprogesterone, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women. J Am Coll Cardiol 2000;36:2154-2159
25. Sorensen MB, Collins P, Ong PJ, Webb CM, Hayward CS, Asbury EA, Gatehouse PD, Elkington AG, Yang GZ, Kubba A, et al. Long-term use of contraceptive depot Medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation 2002;106:1646-1651.
26. Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer 2005;114:448-454. (Pubitemid 40279968)
27. Rosenberg LU, Magnusson C, Lindstrom E, Wedren S, Hall P, Dickman PW. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a casecontrol study. Breast Cancer Res 2006;8:R11. Epub 2006 Feb 17.